Details for New Drug Application (NDA): 012836
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 012836 describes PERSANTINE, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. Additional details are available on the PERSANTINE profile page.
The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 012836
| Tradename: | PERSANTINE |
| Applicant: | Boehringer Ingelheim |
| Ingredient: | dipyridamole |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 012836
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Dec 22, 1986 | TE: | AB | RLD: | Yes | ||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Feb 6, 1987 | TE: | AB | RLD: | Yes | ||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Feb 6, 1987 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
